A broad retreat swept through European equities trading on American exchanges during Tuesday’s session, with most major American depositary receipts finishing the day in negative territory. Novo Nordisk (NYSE: NVO) suffered one of the steeper losses among the group, with shares sliding 1.90% as selling pressure weighed on the Danish pharmaceutical giant throughout the afternoon. […]
Read with caution - this story is only being covered by one news source that has a ‘low factuality’ rating, which means the outlet has a history of poor reporting practices. Learn more about factuality ratings here.